Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lobaplatin vs Paclitaxel in HIPEC for Advanced Gastric Cancer
NCT04808466Phase 2Unknown
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of lobaplatin, paclitaxel in gastric cancer (GC). Status: unknown.
02
Drugs
lobaplatinpaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04808466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808466.